60 Degrees Pharmaceuticals (SXTP) Cash & Equivalents (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) recorded Cash & Equivalents of $1.02 million in Q2 2026, down 48.0% from $1.97 million a year earlier and down 69.4% from the prior quarter.
60 Degrees Pharmaceuticals (SXTP) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, 60 Degrees Pharmaceuticals reported Cash & Equivalents of $1.51 million, down 9.0% from FY2024.
- Annual Cash & Equivalents has a three-year compound annual growth rate of 78.6% (FY2022 to FY2025).
- Across earlier years, Cash & Equivalents came in at $1.66 million in FY2024 (-22.6%), $2.14 million in FY2023 (+708.9%) and $264,865 in FY2022.
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q2 2023.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 4.3% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 708.9% in Q4 2023, against a decline of 97.5% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.34 million (Q1 2026), $1.51 million (Q4 2025) and $4.12 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.32 Mn | 2.22 Mn | 56,798.00 | 1.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | 2.89 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 19,070.00 |
| Mar 31, 2023 | 29,993.00 |
| Dec 31, 2022 | 264,865.00 |
| Sep 30, 2022 | 439,393.00 |
| Jun 30, 2022 | 751,450.00 |
60 Degrees Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SXTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SXTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SXTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();